Risk factors for CVD, the leading cause of premature death in adults with T1DM, are under-recognized and/or undertreated in youth with T1DM, suggesting a need for enhancing prevention and early self-management education efforts. As a first step, this cross-sectional study was conducted to learn about youth with T1DM and their caregivers’ understanding of CVD in relation to DM. Teenagers and young adults with T1DM (n=80; 18.1±1.5y, 41% female, 86% white) attending a DM clinic at a large pediatric academic center and their caregivers (n=64) were surveyed about CVD-DM awareness and self-management practices. Clinical indicators of CVD risk (hemoglobin A1c (HbA1c), blood pressure (BP), and lipid profile) were extracted from medical records. Only 24% youth and 41% caregivers reported that anyone had ever talked to them about the connection between DM and CVD, with the most frequent source being doctors. Merely 14% of youth and 27% caregivers reported having a good/very good understanding of the connection between DM and CVD. Interestingly, 71% of youth and 81% caregivers correctly listed CVD prevention behaviors (e.g., healthy eating, being active), with 35% youth and 44% caregivers listing actions specific to DM care (e.g., good blood glucose control). Most youth and caregivers correctly identified the recommended testing frequency for HbA1c (81% and 78%) and BP (81% and 86%), with fewer youth familiar with the annual testing of lipid profile (41%). A majority of youth and caregivers also correctly listed recommended target values for HbA1c (70% and 77%), but fewer knew target values for BP (25% and 49%) and LDL cholesterol (6% for both groups). In comparison, percentage of youth meeting recommended targeted values for clinical indicators of CVD risk were 29% for HbA1c, 45% for BP, and 70% for LDL cholesterol. These results strongly support a need to raise awareness and address CVD risk and reduction practices as part of ongoing diabetes self-management education.


J. Krall: None. K. Ruppert: None. A.M. Diaz: None. J. Finney: None. L.M. Siminerio: None. I. Libman: Consultant; Self; Novo Nordisk Inc.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.